Join global hematology leaders at Highlights of ASH in North America, a two-day program offered in multiple locations, to explore and discuss the most influential and novel research presented at the latest ASH annual meeting.
Highlights of ASH in North America
Plan to Attend
Highlights of ASH in North America attendees will connect with top hematology experts in person and learn how to apply the latest research to their own areas of expertise. Choose the location that best meets your schedule.
Chicago, Illinois | January 15-16, 2027
New York, New York | January 22-23, 2027
Seattle, Washington | January 22-23, 2027
Washington, D.C. | January 29-30, 2027
Registration will open in October.
“Connecting with colleagues outside my particular area of focus within hematology has been very rewarding. Highlights of ASH is a great place to break out of my comfort zone and keep me up to date on the exciting advances in our field.”
Cutting-edge Research from Across Disciplines
Hear the most influential and novel research in malignant and classical hematology shared at the latest ASH annual meeting.
Instant Insights
Ask questions and get feedback from top hematology experts in real time.
Real Advice You Can Use
Gain insight into local and regional standards of care. Discover how emerging technology can enhance your practice.
Meet Experts in Your Field
Network with colleagues of all career stages and form connections in your field.
Earn CME credits
Attendees can earn continuing medical education (CME) credits for physicians, while non-physicians and other health care professionals may receive a Certificate of Completion.
Meeting Information
Satellite Symposia
Satellite Symposia are industry-sponsored, CME-accredited programs offered in conjunction with ASH specialty meetings. These events are planned solely by the sponsoring company and are not part of official ASH programming. Registration to the ASH meeting is not required to attend, and there is no fee to participate. View Satellite Symposia InformationProgram Schedule
This program is curated for hematologists, oncologists, fellows and trainees, allied health professionals, advanced practice providers, and hematopathologists. The following session topics correspond to the 2027 Highlights of ASH in North America and are subject to change. The program schedule is identical for all 2027 Highlights of ASH North America locations.
| 11:00 a.m. | Registration and Exhibits Open (Lunch provided) | |
| 11:45 a.m. | Welcome and Introductions | |
| 12:00 p.m. | Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Chronic Myeloid Leukemia | |
| Kelly Chien, MD The University of Texas MD Anderson Cancer Center |
Seattle | |
| Aaron T. Gerds, MD, MS Cleveland Clinic and Case Comprehensive Cancer Center |
New York | |
| Naveen Pemmaraju, MD The University of Texas MD Anderson Cancer Center |
Chicago | |
| Katherine Walsh, MD Vanderbilt University Medical Center |
Washington, DC | |
| 12:45 p.m. | Indolent Lymphoma and Chronic Lymphocytic Leukemia | |
| Matthew Cortese, MD, MPH Roswell Park Comprehensive Cancer Center |
New York | |
| Matthew Kang, MD, FRCPC Joseph Brant Hospital |
Chicago & Washington, DC | |
| Krish Patel, MD Sarah Cannon Research Institute |
Seattle | |
| 1:30 p.m. | Aggressive Lymphoma | |
| Jeremy Abramson, MD, MMSc Mass General Brigham Cancer Institute |
New York | |
| Manali Kamdar, MD University of Colorado |
Seattle | |
| Yasmin Karimi, MD University of Michigan |
Washington, DC | |
| Peter Riedell, MD University of Chicago |
Chicago | |
| 2:15 p.m. | Panel Discussion | |
| 2:45 p.m. | Coffee Break and Exhibits Open | |
| 3:00 p.m. | Bleeding Disorders | |
| Mary Ann Knovich, MD Wake Forest School of Medicine, Atrium Health Levine Cancer Institute |
New York | |
| Ming Y. Lim, MBBCh, MS University of Utah |
Seattle | |
| Robert Klaassen, MD, FRCPC Children's Hospital of Eastern Ontario |
Chicago & Washington, DC | |
| 3:45 p.m. | Thrombosis | |
| Gloria Gerber, MD Johns Hopkins University |
Washington, DC | |
| Damon Houghton, MD, MS Mayo Clinic |
Seattle | |
| Alfred Lee, MD, PhD Yale School of Medicine |
Chicago | |
| Rachel Rosovsky, MD, MPH Massachusetts General Hospital |
New York | |
| 4:30 p.m. | Women’s Health and Iron | |
| Jason Freed, MD Harvard Medical School / Beth Israel Deaconess Medical Center |
Washington, DC | |
| Alecia Nero, MD, MSCS UT Health Houston |
Seattle | |
| Layla Van Doren, MD, MBA University of California, San Francisco |
New York | |
| Michelle Sholzberg, MDCM, FRCPC, MSc St. Michael's Hospital, University of Toronto |
Chicago | |
| 5:15 p.m. | Panel Discussion | |
| 5:45 p.m. | Highlights of ASH Day 1 Program Adjournment | |
| 7:00 a.m. | Registration and Exhibits Open (Breakfast provided) | |
| 7:45 a.m. | Welcome and Introductions | |
| 8:00 a.m. | Plasma Cell Disorder & Myeloma | |
| Jack Khouri, MD Cleveland Clinic |
Chicago | |
| Martha Louzada, MD, MSCS London Health Sciences Centre |
Washington, DC | |
| Jorge Monge, MD University of Colorado Anschutz |
Seattle | |
| Ruben Niesvizky, MD Weill Cornell Medicine |
New York | |
| 8:45 a.m. | Transplantation | |
| Uday Deotare, MBBS, MD, MScHQ, DRCPSC London Health Sciences Centre, Western University |
Washington, DC | |
| Hany Elmariah, MD, MS Stanford University |
Seattle | |
| Mehdi Hamadani, MD Medical College of Wisconsin |
Chicago | |
| Hannah Lust, MD Ann & Robert H. Lurie Children's Hospital |
New York | |
| 9:30 a.m. | Complications of Novel Therapies | |
| Nadine Abdallah, MD Mayo Clinic |
New York | |
| Saurabh Dahiya, MD Stanford University |
Washington, DC | |
| Loretta Nastoupil, MD Southwest Oncology/Mercy CommonSpirit |
Chicago & Seattle | |
| 10:15 a.m. | Panel Discussion | |
| 10:45 a.m. | Coffee Break and Exhibits Open | |
| 11:00 a.m. | Acute Lymphoblastic Leukemia | |
| Hannah Levavi, MD Icahn School of Medicine, Mount Sinai Hospital |
New York | |
| John Molina, MD, EdM Cleveland Clinic Taussig Cancer Institute |
Seattle | |
| Susan Rheingold, MD Children's Hospital of Philadelphia |
Chicago & Washington, DC | |
| 11:45 a.m. | Acute Myeloid Leukemia | |
| Bhavana Bhatnagar, DO WVU Cancer Institute in Wheeling |
Chicago & Seattle | |
| Pinkal Desai, MD, MPH Weill Cornell Medicine |
New York | |
| Alison Walker, MD, MPH, MBA Moffitt Cancer Center |
Washington, DC | |
| 12:30 p.m. | Panel Discussion | |
| 1:00 p.m. | Lunch with the Experts (All Speakers and Attendees) | |
| 2:15 p.m. | Hemoglobinopathies and Red Blood Cell Disorders | |
| Maureen Okam Achebe, MD, MPH Brigham and Women's Hospital, Harvard Medical School |
New York | |
| Charity Oyedeji, MD, MHS Duke University |
Washington, DC | |
| Venée Tubman, MD, MMSc Texas Children's Hospital |
Seattle | |
| Omar Niss, MD Cincinnati Children's Hospital Medical Center |
Chicago | |
| 3:00 p.m. | Consultative Hematology | |
| Cyrus Hsia, MD, FRCPC London Health Sciences Centre |
Chicago | |
| Siraj Mithoowani, MD, MHPE, FRCPC, FACP McMaster University |
Seattle | |
| Srikanth Nagalla, MBBS, MS Herbert Wertheim Cancer Institute, Baptist Health South Florida |
New York & Washington, DC | |
| 3:45 p.m. | Beyond the Acute Illness | |
| Elizabeth O’Donnell, MD Dana-Farber Cancer Institute |
New York | |
| Ryan Jacobs, MD Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine |
Seattle | |
| Urvi Shah, MD, MS, DipABLM Memorial Sloan Kettering Cancer Center |
Chicago & Washington, DC | |
| 4:30 p.m. | Panel Discussion | |
| 5:00 p.m. | Closing Remarks and Adjournment | |
Acknowledgments
Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, our State Society Partners, and our company partners for providing educational grants in support of the 2026 Highlights of ASH in North America.
Highlights of ASH Steering Subcommittee
- Alison Walker, MD, MBA, MPH, Chair, Moffitt Cancer Center
- Maureen Okam Achebe, MD, MPH, Brigham and Women’s Hospital
- Jason Freed, MD, Beth Israel Deaconess Medical Center
- Cyrus C. Hsia, MD, FRCPC, London Health Sciences Centre
- Manali Kamdar, MD, University of Colorado
- Mary Ann Knovich, MD, Atrium Health Levine Cancer Institute
- John C. Molina, MD, EdM, Cleveland Clinic
- Ruben Niesvizky, MD, Weill Cornell Medicine
- Rachel P. Rosovsky, MD, Massachusetts General Hospital
- Eric Tse, MBBS, PhD, Hong Kong University
- Robert Zeiser, MD, University of Freiburg